相似文献
1
Eph receptors and ephrins in cancer: bidirectional signalling and beyond.
Nat Rev Cancer. 2010 Mar;10(3):165-80. doi: 10.1038/nrc2806.
2
Eph receptors and ephrins as targets for cancer therapy.
J Cell Mol Med. 2012 Dec;16(12):2894-909. doi: 10.1111/j.1582-4934.2012.01612.x.
3
The role of ephrins and Eph receptors in cancer.
Cytokine Growth Factor Rev. 2004 Dec;15(6):419-33. doi: 10.1016/j.cytogfr.2004.09.002.
4
Eph/ephrin signaling in cancer: intricate, puzzling and ... fascinating!
Cell Adh Migr. 2012 Mar-Apr;6(2):100-1. doi: 10.4161/cam.20890. Epub 2012 Mar 1.
5
Eph receptors and ephrins: therapeutic opportunities.
Annu Rev Pharmacol Toxicol. 2015;55:465-87. doi: 10.1146/annurev-pharmtox-011112-140226. Epub 2014 Oct 3.
6
Role of Eph/ephrin tyrosine kinase in malignant glioma.
Neuro Oncol. 2011 Nov;13(11):1163-70. doi: 10.1093/neuonc/nor102. Epub 2011 Aug 19.
7
Eph-ephrin bidirectional signaling in physiology and disease.
Cell. 2008 Apr 4;133(1):38-52. doi: 10.1016/j.cell.2008.03.011.
8
Eph and ephrins in epithelial stem cell niches and cancer.
Cell Adh Migr. 2012 Mar-Apr;6(2):126-30. doi: 10.4161/cam.18932. Epub 2012 Mar 1.
9
[Role of ephrins in regulation of tumour cell migration].
Postepy Biochem. 2009;55(2):153-62.
10
Eph-ephrin signalling in adult tissues and cancer.
Curr Opin Cell Biol. 2008 Apr;20(2):194-200. doi: 10.1016/j.ceb.2008.01.011. Epub 2008 Mar 18.
引用本文的文献
1
Association of Single-Nucleotide Polymorphisms on and Genes with the Risk and Prognosis of Undifferentiated Nasopharyngeal Cancer.
Int J Mol Sci. 2025 Sep 1;26(17):8486. doi: 10.3390/ijms26178486.
2
EphB2-Targeting Monoclonal Antibodies Exerted Antitumor Activities in Triple-Negative Breast Cancer and Lung Mesothelioma Xenograft Models.
Int J Mol Sci. 2025 Aug 27;26(17):8302. doi: 10.3390/ijms26178302.
3
EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway.
Front Oncol. 2025 Aug 22;15:1620122. doi: 10.3389/fonc.2025.1620122. eCollection 2025.
4
Tumor-Specific EphA2 Receptor Tyrosine Kinase Inhibits Anti-Tumor Immunity by Recruiting Suppressive Myeloid Populations in Murine Models of Non-Small Cell Lung Cancer.
Cancers (Basel). 2025 Aug 19;17(16):2693. doi: 10.3390/cancers17162693.
5
LMP2A regulates S901 phosphorylation of EphA2 to maintain EBV latent infection in gastric cancer.
Br J Cancer. 2025 Aug 9. doi: 10.1038/s41416-025-03131-0.
6
Immunohistochemical determination of the expression of Eph receptors in lipid-rich variation of experimental rat mammary carcinomas.
J Mol Histol. 2025 Jun 27;56(4):208. doi: 10.1007/s10735-025-10501-8.
7
Chronic arsenic exposure and hsa-miR-186 overexpression causes transcriptome-wide differential alternative splicing contributing to skin carcinogenesis in human HaCaT cell line.
Arch Toxicol. 2025 Jun 13. doi: 10.1007/s00204-025-04104-1.
8
Targeting DNA damage in ageing: towards supercharging DNA repair.
Nat Rev Drug Discov. 2025 Jun 12. doi: 10.1038/s41573-025-01212-6.
9
Exploring the complex role of the Eph/Ephrin signaling in oral and maxillofacial cancers.
Front Oncol. 2025 May 12;15:1554751. doi: 10.3389/fonc.2025.1554751. eCollection 2025.
10
EPHA5 promotes cell proliferation and inhibits apoptosis in Follicular Thyroid Cancer via the STAT3 signaling pathway.
Oncogenesis. 2025 Apr 22;14(1):12. doi: 10.1038/s41389-025-00556-3.
本文引用的文献
1
Tsc2-Rheb signaling regulates EphA-mediated axon guidance.
Nat Neurosci. 2010 Feb;13(2):163-72. doi: 10.1038/nn.2477. Epub 2010 Jan 10.
2
Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy.
Cancer Res. 2010 Jan 1;70(1):299-308. doi: 10.1158/0008-5472.CAN-09-1845. Epub 2009 Dec 22.
3
Ephrin expression and function in cancer.
Future Oncol. 2010 Jan;6(1):165-76. doi: 10.2217/fon.09.146.
4
Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells.
Science. 2009 Dec 11;326(5959):1502-9. doi: 10.1126/science.1176615.
5
Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles.
Nanomedicine. 2010 Jun;6(3):399-408. doi: 10.1016/j.nano.2009.11.003. Epub 2009 Dec 5.
6
Cell signaling in space and time: where proteins come together and when they're apart.
Science. 2009 Nov 27;326(5957):1220-4. doi: 10.1126/science.1175668.
7
Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression.
Cell. 2009 Nov 13;139(4):679-92. doi: 10.1016/j.cell.2009.08.048.
8
A role for C. elegans Eph RTK signaling in PTEN regulation.
Dev Cell. 2009 Oct;17(4):459-69. doi: 10.1016/j.devcel.2009.08.009.
9
Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation.
Science. 2009 Oct 9;326(5950):294-8. doi: 10.1126/science.1178577.
10
Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).
J Med Chem. 2009 Oct 22;52(20):6433-46. doi: 10.1021/jm9009444.
Zotero 插件